AstraZeneca PLC (LON:AZN)
London · Delayed Price · Currency is GBP · Price in GBX 11,166
+376 (3.48%)
Jul 29, 2025, 3:06 PM BST
AstraZeneca Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 56,501 | 54,073 | 45,811 | 44,351 | 37,417 | 26,617 | Upgrade |
| 56,501 | 54,073 | 45,811 | 44,351 | 37,417 | 26,617 | Upgrade | |
Revenue Growth (YoY) | 15.00% | 18.04% | 3.29% | 18.53% | 40.58% | 9.16% | Upgrade |
Cost of Revenue | 9,967 | 9,638 | 8,040 | 8,641 | 12,005 | 5,246 | Upgrade |
Gross Profit | 46,534 | 44,435 | 37,771 | 35,710 | 25,412 | 21,371 | Upgrade |
Selling, General & Admin | 19,437 | 19,453 | 18,025 | 17,460 | 14,673 | 11,586 | Upgrade |
Research & Development | 13,256 | 12,243 | 10,373 | 9,669 | 8,049 | 5,901 | Upgrade |
Other Operating Expenses | -255 | -190 | -275 | -231 | -207 | -486 | Upgrade |
Operating Expenses | 32,438 | 31,506 | 28,123 | 26,898 | 22,515 | 17,001 | Upgrade |
Operating Income | 14,096 | 12,929 | 9,648 | 8,812 | 2,897 | 4,370 | Upgrade |
Interest Expense | -1,332 | -1,403 | -1,219 | -917 | -776 | -738 | Upgrade |
Interest & Investment Income | 283 | 345 | 301 | 81 | 43 | 77 | Upgrade |
Earnings From Equity Investments | -26 | -28 | -12 | -5 | -64 | -27 | Upgrade |
Currency Exchange Gain (Loss) | -42 | -42 | -34 | -16 | -20 | -34 | Upgrade |
Other Non Operating Income (Expenses) | -134 | -134 | -292 | -370 | -478 | -487 | Upgrade |
EBT Excluding Unusual Items | 12,845 | 11,667 | 8,392 | 7,585 | 1,602 | 3,161 | Upgrade |
Merger & Restructuring Charges | -1,000 | -1,154 | -604 | -4,201 | -1,283 | -251 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | 776 | - | Upgrade |
Gain (Loss) on Sale of Assets | 60 | 60 | 292 | 216 | 509 | 1,055 | Upgrade |
Asset Writedown | -1,574 | -1,574 | -434 | -241 | -2,069 | -252 | Upgrade |
Legal Settlements | -48 | -48 | -1,013 | -789 | -48 | 9 | Upgrade |
Other Unusual Items | -260 | -260 | 266 | -69 | 248 | 194 | Upgrade |
Pretax Income | 10,023 | 8,691 | 6,899 | 2,501 | -265 | 3,916 | Upgrade |
Income Tax Expense | 1,721 | 1,650 | 938 | -792 | -380 | 772 | Upgrade |
Earnings From Continuing Operations | 8,302 | 7,041 | 5,961 | 3,293 | 115 | 3,144 | Upgrade |
Minority Interest in Earnings | -7 | -6 | -6 | -5 | -3 | 52 | Upgrade |
Net Income | 8,295 | 7,035 | 5,955 | 3,288 | 112 | 3,196 | Upgrade |
Net Income to Common | 8,295 | 7,035 | 5,955 | 3,288 | 112 | 3,196 | Upgrade |
Net Income Growth | 28.80% | 18.14% | 81.11% | 2835.71% | -96.50% | 139.40% | Upgrade |
Shares Outstanding (Basic) | 1,550 | 1,550 | 1,549 | 1,548 | 1,418 | 1,312 | Upgrade |
Shares Outstanding (Diluted) | 1,563 | 1,563 | 1,562 | 1,560 | 1,427 | 1,313 | Upgrade |
Shares Change (YoY) | 0.06% | 0.06% | 0.13% | 9.32% | 8.68% | 0.92% | Upgrade |
EPS (Basic) | 5.35 | 4.54 | 3.84 | 2.12 | 0.08 | 2.44 | Upgrade |
EPS (Diluted) | 5.30 | 4.50 | 3.81 | 2.11 | 0.08 | 2.44 | Upgrade |
EPS Growth | 28.31% | 18.11% | 80.57% | 2571.43% | -96.76% | 137.39% | Upgrade |
Free Cash Flow | 11,176 | 9,937 | 8,984 | 8,717 | 4,872 | 3,838 | Upgrade |
Free Cash Flow Per Share | 7.15 | 6.36 | 5.75 | 5.59 | 3.41 | 2.92 | Upgrade |
Dividend Per Share | 2.100 | 3.100 | 2.900 | 2.900 | 2.870 | 2.800 | Upgrade |
Dividend Growth | -29.29% | 6.90% | - | 1.04% | 2.50% | - | Upgrade |
Gross Margin | 82.36% | 82.18% | 82.45% | 80.52% | 67.92% | 80.29% | Upgrade |
Operating Margin | 24.95% | 23.91% | 21.06% | 19.87% | 7.74% | 16.42% | Upgrade |
Profit Margin | 14.68% | 13.01% | 13.00% | 7.41% | 0.30% | 12.01% | Upgrade |
Free Cash Flow Margin | 19.78% | 18.38% | 19.61% | 19.66% | 13.02% | 14.42% | Upgrade |
EBITDA | 18,899 | 17,567 | 14,224 | 13,744 | 6,701 | 6,990 | Upgrade |
EBITDA Margin | 33.45% | 32.49% | 31.05% | 30.99% | 17.91% | 26.26% | Upgrade |
D&A For EBITDA | 4,803 | 4,638 | 4,576 | 4,932 | 3,804 | 2,620 | Upgrade |
EBIT | 14,096 | 12,929 | 9,648 | 8,812 | 2,897 | 4,370 | Upgrade |
EBIT Margin | 24.95% | 23.91% | 21.06% | 19.87% | 7.74% | 16.42% | Upgrade |
Effective Tax Rate | 17.17% | 18.98% | 13.60% | - | - | 19.71% | Upgrade |
Revenue as Reported | 56,501 | 54,073 | 45,811 | 44,351 | 37,417 | 26,617 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.